Axogen (AXGN) Completes Acquisition of BioCircuit Technologies

AI-generated NewsSnap summary based on source reporting.
Published: 2026-10-04
Category: business
Source: Foreign Policy Journal

Axogen, Inc. (NASDAQ: AXGN) has completed its acquisition of BioCircuit Technologies, adding NerveTape, the first FDA-cleared device for sutureless peripheral nerve repair, to its portfolio.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai